{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CLPBF"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CLPBF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CLPBF\",,,,,undefined,":{"symbol":"CLPBF","market":"US","secType":"STK","nameCN":"Coloplast AS","latestPrice":93.25,"timestamp":1752682620000,"preClose":93.25,"halted":0,"volume":0,"delay":15,"floatShares":141989600,"shares":224840059,"eps":3.239627,"marketStatus":"Trading","change":0,"latestTime":"07-16 12:17:00 EDT Delay","open":93.25,"high":93.25,"low":93.25,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":3.239627,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1752696000000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"PINK LIMITED","adjPreClose":93.25,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CLPBF\",,,,,undefined,":{"symbol":"CLPBF","floatShares":141989600,"roa":"9.64%","roe":"27.42%","lyrEps":3.149522,"shares":224840059,"dividePrice":3.304881,"high":93.25,"amplitude":0,"preClose":93.25,"low":93.25,"week52Low":90.57,"pbRate":"8.41","psRate":"5.13","week52High":140.315,"institutionHeld":0,"latestPrice":93.25,"eps":3.239627,"divideRate":0.035441,"volume":0,"delay":15,"ttmEps":3.239627,"open":93.25,"prevYearClose":108.281,"prevWeekClose":93.25,"prevMonthClose":90.57,"prevQuarterClose":90.57,"fiveDayClose":93.25,"twentyDayClose":100,"sixtyDayClose":98.61},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/CLPBF\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CLPBF\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2532073717","title":"Coloplast A/S Revised guidance for FY 2024/25","url":"https://stock-news.laohu8.com/highlight/detail?id=2532073717","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532073717?lang=en_us&edition=fundamental","pubTime":"2025-05-01 18:23","pubTimestamp":1746094980,"startTime":"0","endTime":"0","summary":"Coloplast revises financial guidance for FY 2024/25 and pre-announces H1 2024/25 key financial figures. Coloplast revises the guidance on organic growth and EBIT margin before special items for FY 2024/25. The organic growth is now expected to be around 7%, from previously 8-9%. The EBIT margin before special items is now expected to be 27-28%, from previously around 28%.Group organic growth was 6% in Q2. The EBIT margin before special items was 27%.Organic growth rates by business area: Ostomy Care 4%, Continence Care 8%, Voice and Respiratory Care 7%, Advanced Wound Care 10% and Interventional Urology -1%.The slower growth in Ostomy Care was due to a high baseline in Europe, tender phasing in Emerging markets and a slow-down in China. Growth in Ostomy Care is expected to pick up in the second half of the year compared to Q2.Voice and Respiratory Care growth was driven by both Laryngectomy and Tracheostomy, against a high baseline last year.Special Items are now expected to be around ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/coloplast-revised-guidance-fy-2024-102300730.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CLPBF","BK4198","CLPBY"],"gpt_icon":0},{"id":"2527841345","title":"Coloplast A/S - H1 2024/25 Earnings Release - Invitation to conference call on 6 May 2025 at 11.00am CEST","url":"https://stock-news.laohu8.com/highlight/detail?id=2527841345","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527841345?lang=en_us&edition=fundamental","pubTime":"2025-04-15 20:05","pubTimestamp":1744718700,"startTime":"0","endTime":"0","summary":"Tuesday, 6 May 2025 at 11.00 - 12.00am CESTIn connection with the publication of Coloplast’s interim financial results for H1 2024/25, to be released same day around 07.30am CEST, Coloplast will host a conference call to present the financial results and answer questions from investors and financial analysts. A presentation will be available on Coloplast’s website approximately 1 hour before the conference call.The webcast of the conference call will be available during and after the event.Coloplast will be represented by: Kristian Villumsen-President & CEOAnders Lonning-Skovgaard-Executive Vice President, CFOAleksandra Dimovska - Vice President, Investor RelationsSimone Dyrby Helvind - Senior Manager, Investor Relations. WebcastFor participants who do not wish to actively participate in the Q&A session, please access the conference call as a webcast via the link below:Access the webcast here. Dial-in detailsTo actively participate in the Q&A session, please sign up ahead of the confer","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/coloplast-h1-2024-25-earnings-120500728.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CLPBF","CLPBY"],"gpt_icon":0},{"id":"2509332420","title":"Coloplast AS (CLPBF) Q1 2025 Earnings Call Highlights: Strong Organic Growth and Strategic ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2509332420","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509332420?lang=en_us&edition=fundamental","pubTime":"2025-02-05 15:04","pubTimestamp":1738739042,"startTime":"0","endTime":"0","summary":"EBIT Margin Before Special Items: 27% in Q1.Revenue Increase: DKK420 million or 6% compared to last year.Gross Margin: 68%, on par with last year.Operating Profit Before Special Items: DKK1.9 billion, a 5% increase compared to last year.Net Profit Before Special Items: DKK1.4 billion, a 17% increase compared to last year.Adjusted Diluted Earnings Per Share: DKK6.38, a 17% increase.CapEx: DKK308 million with a CapEx to sales ratio of 4%.Advanced Wound Care Organic Growth: 12% in Q1.Voice and Respiratory Care Growth: 11% in Q1.Effective Tax Rate: 41% due to extraordinary tax expense.GuruFocus has detected 4 Warning Signs with CLPBF.Coloplast AS  reported 8% organic growth and a 27% EBIT margin before special items, aligning with expectations.A: We don't run a perfect company, and we've had setbacks related to the distribution center and a quality problem in urology. We've addressed these issues, and the distribution center is back to service levels. We manufacture over 1.5 billion medica","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/coloplast-clpbf-q1-2025-earnings-070402410.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CLPBF","CLPBY"],"gpt_icon":0},{"id":"2508353453","title":"Coloplast A/S - Allocation of Share Options","url":"https://stock-news.laohu8.com/highlight/detail?id=2508353453","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508353453?lang=en_us&edition=fundamental","pubTime":"2025-02-04 20:12","pubTimestamp":1738671120,"startTime":"0","endTime":"0","summary":"Report on transactions of executives and related parties in Coloplast shares and related securities. According to the Market Abuse Regulation article 19 Coloplast is obliged to report on the transactions of executives and their related parties in Coloplast shares and related securities.The below transactions concern allocation of share options.For further details, reference is made to Coloplast’s Remuneration Policy. The policy is available on the group website at this address:. Details of the issuer, emission allowance market participant, auction platform, auctioneer, or auction monitor. Details of the transaction: section to be repeated for  each type of instrument;  each type of transaction;  each date; and  each place where transactions have been conducted. Description of the financial instrument, type of instrument","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/coloplast-allocation-share-options-121200791.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CLPBY","CVR","CLPBF","BK4161","BK4198"],"gpt_icon":0}],"pageSize":4,"totalPage":4,"pageCount":1,"totalSize":13,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CLPBF\",params:#limit:5,,,undefined,":[{"date":"2025-05-08","symbol":"CLPBF","amount":5,"announcedDate":"2025-05-06","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-05-09","defaultRemindTime":1746711000000,"name":"Coloplast AS","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-12","payableDate":"2025-05-09","currency":"DKK","dateTimestamp":1746676800000,"payDate":"2025-05-12"},{"date":"2024-12-06","symbol":"CLPBF","amount":17,"announcedDate":"2024-11-05","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-09","defaultRemindTime":1733495400000,"name":"Coloplast AS","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-10","payableDate":"2024-12-09","currency":"DKK","dateTimestamp":1733461200000,"payDate":"2024-12-10"},{"date":"2024-05-13","symbol":"CLPBF","amount":5,"announcedDate":"2024-05-07","type":"dividend","market":"US","newRecordDate":"2024-05-14","defaultRemindTime":1715607000000,"name":"Coloplast AS","recordDate":"2024-05-15","payableDate":"2024-05-14","currency":"DKK","dateTimestamp":1715572800000,"payDate":"2024-05-15"},{"date":"2024-05-07","symbol":"CLPBF","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1715068800000,"name":null,"time":"","dateTimestamp":1715054400000,"actualEps":null},{"date":"2023-12-08","symbol":"CLPBF","amount":16,"announcedDate":"2023-11-09","type":"dividend","market":"US","newRecordDate":"2023-12-11","defaultRemindTime":1702045800000,"name":"Coloplast AS","recordDate":"2023-12-12","payableDate":"2023-12-11","currency":"DKK","dateTimestamp":1702011600000,"payDate":"2023-12-12"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CLPBF\",market:\"US\",,,undefined,":[{"executeDate":"2018-12-06","recordDate":"2018-12-07","paymentDate":"2018-12-10","value":11,"currency":"DKK"},{"executeDate":"2019-05-06","recordDate":"2019-05-07","paymentDate":"2019-05-08","value":5,"currency":"DKK"},{"executeDate":"2019-12-06","recordDate":"2019-12-09","paymentDate":"2019-12-10","value":12,"currency":"DKK"},{"executeDate":"2020-05-11","recordDate":"2020-05-12","paymentDate":"2020-05-13","value":5,"currency":"DKK"},{"executeDate":"2020-12-04","recordDate":"2020-12-07","paymentDate":"2020-12-08","value":13,"currency":"DKK"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CLPBF\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.6667,"buy":0,"hold":0.3333,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0,"analysts":3,"updateTime":1746590400000}}}